Cargando…
Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel
During 1996–1997, a new Vibrio vulnificus biotype 3, which caused severe soft tissue infection after fishbone injury, emerged in Israel. We conducted a follow-up study from 1998 through 2005 to assess changing trends, outcomes, and molecular relatedness of the implicated strains. A total of 132 case...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634625/ https://www.ncbi.nlm.nih.gov/pubmed/19046510 http://dx.doi.org/10.3201/eid1412.080499 |
_version_ | 1782164130581446656 |
---|---|
author | Zaidenstein, Ronit Sadik, Chantal Lerner, Larisa Valinsky, Lea Kopelowitz, June Yishai, Ruth Agmon, Vered Parsons, Michele Bopp, Cheryl Weinberger, Miriam |
author_facet | Zaidenstein, Ronit Sadik, Chantal Lerner, Larisa Valinsky, Lea Kopelowitz, June Yishai, Ruth Agmon, Vered Parsons, Michele Bopp, Cheryl Weinberger, Miriam |
author_sort | Zaidenstein, Ronit |
collection | PubMed |
description | During 1996–1997, a new Vibrio vulnificus biotype 3, which caused severe soft tissue infection after fishbone injury, emerged in Israel. We conducted a follow-up study from 1998 through 2005 to assess changing trends, outcomes, and molecular relatedness of the implicated strains. A total of 132 cases (71% confirmed and 29% suspected) of V. vulnificus biotype 3 infection were found. Most infections (95%) were related to percutaneous fish exposure, mainly tilapia (83%) or common carp (13%). Bacteremia, altered immune status, and history of ischemic heart disease were identified as independent risk factors for death, which reached a prevalence of 7.6%. Pulsed-field gel electrophoresis patterns of strains from 1998 through 2005 and from 1996 through 1997 showed a high degree of homogeneity and were distinct from those of V. vulnificus biotype 1. Infections caused by V. vulnificus biotype 3 continue affect the public’s health in Israel. |
format | Text |
id | pubmed-2634625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-26346252009-02-09 Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel Zaidenstein, Ronit Sadik, Chantal Lerner, Larisa Valinsky, Lea Kopelowitz, June Yishai, Ruth Agmon, Vered Parsons, Michele Bopp, Cheryl Weinberger, Miriam Emerg Infect Dis Research During 1996–1997, a new Vibrio vulnificus biotype 3, which caused severe soft tissue infection after fishbone injury, emerged in Israel. We conducted a follow-up study from 1998 through 2005 to assess changing trends, outcomes, and molecular relatedness of the implicated strains. A total of 132 cases (71% confirmed and 29% suspected) of V. vulnificus biotype 3 infection were found. Most infections (95%) were related to percutaneous fish exposure, mainly tilapia (83%) or common carp (13%). Bacteremia, altered immune status, and history of ischemic heart disease were identified as independent risk factors for death, which reached a prevalence of 7.6%. Pulsed-field gel electrophoresis patterns of strains from 1998 through 2005 and from 1996 through 1997 showed a high degree of homogeneity and were distinct from those of V. vulnificus biotype 1. Infections caused by V. vulnificus biotype 3 continue affect the public’s health in Israel. Centers for Disease Control and Prevention 2008-12 /pmc/articles/PMC2634625/ /pubmed/19046510 http://dx.doi.org/10.3201/eid1412.080499 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Zaidenstein, Ronit Sadik, Chantal Lerner, Larisa Valinsky, Lea Kopelowitz, June Yishai, Ruth Agmon, Vered Parsons, Michele Bopp, Cheryl Weinberger, Miriam Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel |
title | Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel |
title_full | Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel |
title_fullStr | Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel |
title_full_unstemmed | Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel |
title_short | Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel |
title_sort | clinical characteristics and molecular subtyping of vibrio vulnificus illnesses, israel |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634625/ https://www.ncbi.nlm.nih.gov/pubmed/19046510 http://dx.doi.org/10.3201/eid1412.080499 |
work_keys_str_mv | AT zaidensteinronit clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT sadikchantal clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT lernerlarisa clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT valinskylea clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT kopelowitzjune clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT yishairuth clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT agmonvered clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT parsonsmichele clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT boppcheryl clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael AT weinbergermiriam clinicalcharacteristicsandmolecularsubtypingofvibriovulnificusillnessesisrael |